Avanos Medical (AVNS) Research & Development (2013 - 2026)

Avanos Medical has disclosed Research & Development across 14 years of filings, most recently posting $5.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 3.7% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $23.1 million (down 6.1% YoY), while the FY2025 annual figure was $23.3 million, down 11.07% from the prior year.
• Research & Development came in at $5.2 million for Q1 2026 at Avanos Medical, down from $6.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.8 million in Q1 2022 to a low of $5.2 million in Q1 2026.
• Average Research & Development over 5 years is $6.6 million, with a median of $6.8 million recorded in 2023.
• Year-over-year, Research & Development advanced 22.03% in 2022 and dropped 22.86% in 2025.
• Over 5 years, Research & Development stood at $7.2 million in 2022, then decreased by 5.56% to $6.8 million in 2023, then dropped by 16.18% to $5.7 million in 2024, then grew by 7.02% to $6.1 million in 2025, then retreated by 14.75% to $5.2 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.2 million in Q1 2026, $6.1 million in Q4 2025, and $6.0 million in Q3 2025.